Skip to main content
. 2020 Jun 14;12(6):1570. doi: 10.3390/cancers12061570

Figure 7.

Figure 7

Si306 and pro-Si306 inhibit Src activity in primary GBM cells. Flow-cytometric profiles of Src and pSrc expression in primary GBM, U87, and U87-TxR cells treated with Si306 and pro-Si306. GBM-4, GBM-5, and GBM-6 cells were treated with 10 µM Si306 and pro-Si306 for 24 h, while U87 and U87-TxR cells were treated with 5 µM Si306 and pro-Si306 for 24 h. Histogram represents relative pSrc/Src expression. Values are expressed as mean ± SEM. Statistical significance between treated and control group is shown as ** (p < 0.01), and *** (p < 0.001).